The question and the sample — from 1 435 companies to eleven
Chapter 1 of 15 · 12 min
Jim Collins — the Stanford researcher who wrote Built to Last with Jerry Porras in 1994 — began a five-year research project in Boulder, Colorado, in 1996, with a question that is analysis in its purest form: why do some companies make the leap from good to great while comparable companies do not? The book's first sentence is the whole program: good is the enemy of great — the good is the enemy of the great, because the good is comfortable enough that it never forces the choice. The course begins where the book begins: with the research design. For an AK1A analyst, the methods chapter is not an appendix — it is the most instructive part of the entire book.
The design, quoted openly. The research team — more than twenty people over five years — started with the universe: the 1 435 companies that appeared on the Fortune 500 lists between 1965 and 1995. They then screened, with no theory behind them (the opposite of hypothesis-driven research: they let the data speak), for companies showing a transition point — a shift from persistent mediocrity to lasting greatness — measured as cumulative stock returns of at least THREE times the general market over FIFTEEN years after the shift.
The funnel: 1 435 companies, of which 126 moved on in the first cut, nineteen after tougher requirements — and after sector waves had been cleaned out (entire industries flying high did not count as proof of the company's greatness, but of the industry's) eleven remained. Eleven companies that had beaten the market by an average of around seven times over fifteen years after their leap — Circuit City a full 18,5 times.
The eleven: Abbott, Circuit City, Fannie Mae, Gillette, Kimberly-Clark, Kroger, Nucor, Philip Morris, Pitney Bowes, Walgreens and Wells Fargo. Note the sample's two methodological choices, which are gold for the analyst. First, greatness was measured EX ANTE in the share price, not in reputation — companies were not chosen for being famous or admired but for having delivered a measurable impossibility. Second, a transition point was defined: the leap is an EVENT in a time series, not a gradual honorary title.
That makes the question falsifiable: what happened in these companies at this date that did not happen in comparable companies? That is the comparison set's task — the next chapter. The research work: 87 interviews with key people, tens of thousands of pages of articles, everything coded without any prior theory of what would emerge — Collins calls the process chaos to concept.
The sample's pedagogical point for AK1A: the definition of good is the analysis's first decision. Collins defined GREAT as a number before he knew which companies were involved — three times the market over fifteen years after a leap — and then let the definition sort. Most investors do the opposite: they start with companies they like and then look for measures that glorify the choice in hindsight. The difference is the difference between research and halo — words the controversy chapter returns to, because Collins's design too has a built-in problem: selecting companies ON the outcome makes every pattern you subsequently find suspect.
Both halves of that insight — definition before outcome, and distrust of patterns in outcome-selected samples — are the course's first and most transferable straitjacket.
AKM1 bridge: AKM1 is the same design idea turned into a tool: twenty variables are scored on the same scales every quarter BEFORE any conclusion is drawn — the definition before the names, the measurement before the story.
The AK1TS lesson is the same: deterministic rules, the same data gives the same answer. The course's first line: research design is not a methods chapter — it is the discipline of analysis itself.